Chimin Health Management Co

Chimin Health Management Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Chimin Health Management Co (603222.SS) as of Nov 3, 2026 is 1.89. In the previous year, Financial Leverage (Equity Multiplier) was 1.63 — a change of 16.17% (higher).

Financial Leverage

1.89

YoY

16.17%

Last updated:

Financial Leverage (Equity Multiplier) of Chimin Health Management Co is 2025 1.89 . Financial Leverage (Equity Multiplier) of Chimin Health Management Co was 2024 1.63 . It decreases by 16.17% higher compared to the previous year.

The Chimin Health Management Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
2.62 CNY
Jan 1, 2019
2.39 CNY
Jan 1, 2020
2.65 CNY
Jan 1, 2021
1.96 CNY
Jan 1, 2022
1.59 CNY
Jan 1, 2023
1.57 CNY
Jan 1, 2024
1.63 CNY
Jan 1, 2025
1.89 CNY
The Chimin Health Management Co Financial Leverage history
YEARFinancial LeverageYoY
1.89+16.17%
1.63+3.62%
1.57-1.04%
1.59-18.80%
1.96-26.12%
2.65+10.89%
2.39-8.91%
2.62+32.21%
1.98+61.65%
1.23+4.89%
1.17-17.96%
1.43—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Chimin Health Management Co Stock analysis

What does Chimin Health Management Co do? Chimin Health Management Co., Ltd. generates revenue through the manufacturing and sale of pharmaceutical products, primarily focusing on Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, and injection and puncture machinery such as safety syringes, sterile syringes, and infusion sets. The company serves domestic and overseas markets, with its products distributed across these regions. Its core business involves producing medical devices and pharmaceutical packaging solutions for healthcare providers and distributors. The firm's product portfolio includes Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, and injection and puncture machinery products, which are sold to healthcare institutions and distributors within China and internationally. These products are essential for medical procedures requiring sterile fluid delivery and safe injection practices. Chimin Health Management's domestic market presence is complemented by its international distribution channels. Chimin Health Management Co., Ltd. operates with a workforce of 1,851 full-time employees, supporting its manufacturing and sales operations. The company's revenue streams are derived from the direct sale of its pharmaceutical and medical device products to healthcare providers and distributors, both within China and abroad. Its focus on Non Polyvinyl chloride (PVC) soft bag infusion products and related medical equipment positions it as a key supplier in the healthcare sector. Chimin Health Management Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chimin Health Management Co stock

Financial Leverage (Equity Multiplier) of Chimin Health Management Co is 1.89 in 2025.

Financial Leverage (Equity Multiplier) of Chimin Health Management Co changed from 1.63 to 1.89, representing a 16.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Chimin Health Management Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Chimin Health Management Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Chimin Health Management Co

All Key Metrics — Chimin Health Management Co